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1. Introduction {#efs25319-sec-0002}
===============

Article 3 of the Regulation (EC) No 1332/2008[1](#efs25319-note-1007){ref-type="fn"} provides definitions for 'food enzyme' and 'food enzyme preparation'.

'Food enzyme' means a product obtained from plants, animals or micro‐organisms or products thereof including a product obtained by a fermentation process using micro‐organisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods.

'Food enzyme preparation' means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution.

Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008[2](#efs25319-note-1008){ref-type="fn"} established European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed,there is a reasonable technological need, andits use does not mislead the consumer.

All food enzymes currently on the EU market and intended to remain on that market as well as all new food enzymes shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list.

The 'Guidance on submission of a dossier on food enzymes for safety evaluation' (EFSA CEF Panel, [2009](#efs25319-bib-0008){ref-type="ref"}) lays down the administrative, technical and toxicological data required.

1.1. Background and Terms of Reference as provided by the requestor {#efs25319-sec-0003}
-------------------------------------------------------------------

### 1.1.1. Background as provided by the European Commission {#efs25319-sec-0004}

Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7 (2) of Regulation (EC) No 1332/2008 on food enzymes.

Three applications have been introduced by the company Novozymes A/S for the authorisation of the food enzymes Alpha‐amylase from a genetically modified strain of *Bacillus licheniformis* (strain NZYM‐BC), Amyloglucosidase from a genetically modified strain of *Aspergillus niger* (strain NZYM‐BR) and Glucose oxidase from a genetically modified strain of *Aspergillus oryzae* (strain NZYM‐KP).

Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/2011[3](#efs25319-note-1009){ref-type="fn"} implementing Regulation (EC) No 1331/2008, the Commission has verified that the application falls within the scope of the food enzyme Regulation and contains all the elements required under Chapter II of that Regulation.

### 1.1.2. Terms of Reference {#efs25319-sec-0005}

The European Commission requests the European Food Safety Authority to carry out the safety assessments on the food enzymes Alpha‐amylase from a genetically modified strain of *Bacillus licheniformis* (strain NZYM‐BC), Amyloglucosidase from a genetically modified strain of *Aspergillus niger* (strain NZYM‐BR) and Glucose oxidase from a genetically modified strain of *Aspergillus oryzae* (strain NZYM‐KP) in accordance with Article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.

1.2. Interpretation of the Terms of Reference {#efs25319-sec-0006}
---------------------------------------------

The present scientific opinion addresses the European Commission\'s request to carry out the safety assessment of the food enzyme glucose oxidase from a genetically modified strain of *Aspergillus oryzae* (strain NZYM‐KP).

1.3. Information on existing authorisations and evaluations {#efs25319-sec-0007}
-----------------------------------------------------------

The applicant reports that Danish and French authorities have evaluated and authorised the use of glucose oxidase from a genetically modified strain of *A. oryzae* (strain NZYM‐KP) in baking processes. The Danish authority also sets out the conditions of use, including the dosages for specific foods, which is up to 500 GODU/kg flour.

2. Data and methodologies {#efs25319-sec-0008}
=========================

2.1. Data {#efs25319-sec-0009}
---------

The applicant has submitted a dossier supporting the application for authorisation of the food enzyme glucose oxidase from a genetically modified strain of *A. oryzae* (strain NZYM‐KP). The food enzyme is intended to be used in baking processes.

2.2. Methodologies {#efs25319-sec-0010}
------------------

The assessment was conducted in line with the principles described in the EFSA 'Guidance on transparency in the scientific aspects of risk assessment' (EFSA, [2009](#efs25319-bib-0005){ref-type="ref"}) and following the relevant existing guidances from the EFSA Scientific Committee.

The current 'Guidance on submission of a dossier on food enzymes for safety evaluation' (EFSA CEF Panel, [2009](#efs25319-bib-0008){ref-type="ref"}) has been followed for the evaluation of the application with the exception of the exposure assessment, which was carried out in accordance to the methodology described in the CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, [2016](#efs25319-bib-0009){ref-type="ref"}).

3. Assessment {#efs25319-sec-0011}
=============

3.1. Technical data {#efs25319-sec-0012}
-------------------

### 3.1.1. Identity of the food enzyme {#efs25319-sec-0013}

IUBMB nomenclature: Glucose oxidase

Systematic name: Beta‐[d]{.smallcaps}‐glucose:oxygen 1‐oxidoreductase

Synonyms: Beta‐[d]{.smallcaps}‐glucose oxidase; beta‐[d]{.smallcaps}‐glucose:quinone oxidoreductase

IUBMB No: EC 1.1.3.4

CAS No: 9001‐37‐0

EINECS No: 232‐601‐0

### 3.1.2. Chemical parameters {#efs25319-sec-0014}

The glucose oxidase produced with the genetically modified *A. oryzae* strain NZYM‐SP is a single polypeptide chain of 581 amino acids. The molecular mass derived from the amino acid sequence was calculated to be 63 kDa. The protein homogeneity status of the food enzyme was investigated by sodium dodecyl sulfate‐poly acrylamide gel electrophoresis (SDS‐PAGE) analysis. The apparent molecular mass based on this technique is about 82--88 kDa identified with one band. The difference is expected to be due to glycosylation.

The food enzyme has been tested for other enzymatic activities. The protease, alpha‐amylase, lipase and glucoamylase activities were below the detection limits of the employed methods. The food enzyme shows catalase activity, according to the applicant, the average activity of catalase determined in the three commercial batches is substantially lower than the activities in commercial catalase food enzymes.

Data on the chemical parameters of the food enzyme have been provided for three commercial batches and one batch used for the toxicological tests (Table [1](#efs25319-tbl-0001){ref-type="table"}). The average total organic solids (TOS) content of the three commercial food enzyme batches was 9.8% (w/w); the values ranged from 8.9% to 11.4% (Table [1](#efs25319-tbl-0001){ref-type="table"}). The TOS content is a calculated value derived as 100% minus % water minus % ash.

The enzyme activity/TOS ratio of the three commercial food enzyme batches ranged from 50.53 to 93.71 GODU/mg TOS (Table [1](#efs25319-tbl-0001){ref-type="table"}). The average value of 72 GODU/mg TOS was used for subsequent calculations.

###### 

Compositional data provided for the food enzyme

  Parameter                                                           Unit                                                  Batch                   
  ------------------------------------------------------------------- ----------------------------------------------------- ------- ------- ------- -------
  Glucose oxidase activity                                            GODU/g batch[b](#efs25319-note-0008){ref-type="fn"}   8,340   6,450   5,760   4,790
  Protein                                                             \%                                                    7.44    6.50    7.13    4.88
  Ash                                                                 \%                                                    2.5     2.4     2.3     2.4
  Water                                                               \%                                                    88.6    88.6    86.3    86.9
  Total organic solids (TOS)[c](#efs25319-note-0009){ref-type="fn"}   \%                                                    8.9     9.0     11.4    10.7
  Glucose oxidase activity/mg TOS                                     GODU/mg TOS                                           93.7    71.7    50.5    44.7

Batch used for the toxicological tests.

GODU: Glucose Oxidase Units (see Section [3.1.3](#efs25319-sec-0015){ref-type="sec"}).

TOS calculated as 100% -- % water -- % ash.

John Wiley & Sons, Ltd

The food enzyme complies with the specification for lead (not more than 5 mg/kg) as laid down in the general specifications and considerations for enzymes used in food processing (FAO/WHO, [2006](#efs25319-bib-0011){ref-type="ref"}). In addition, the levels of arsenic, cadmium and mercury in the four batches were below the limits of detection of the employed methodologies.[4](#efs25319-note-1010){ref-type="fn"}

The presence of secondary metabolites (beta‐nitropropionic acid and cyclopiazonic acid) was examined in the four food enzyme batches and they were below the limits of detection of the applied analytical methods.

The food enzyme complies with the microbiological criteria as laid down in the general specifications and considerations for enzymes used in food processing (FAO/WHO, [2006](#efs25319-bib-0011){ref-type="ref"}), which stipulate that *Escherichia coli* and *Salmonella* species are absent in 25 g of sample and total coliforms should not exceed 30 colony forming units (CFU) per gram.

The applicant has provided information on the identities of the antifoam agents used. Taking into account the nature and properties of the antifoam agents, the manufacturing process and the quality assurance system implemented by the applicant, the Panel considers their use as of no safety concern.

The Panel considered the compositional data provided for the food enzyme as sufficient.

### 3.1.3. Properties of the food enzyme {#efs25319-sec-0015}

The glucose oxidase catalyses the oxidation of β‐[d]{.smallcaps}‐glucose to [d]{.smallcaps}‐glucono‐δ‐lactone and hydrogen peroxide using molecular oxygen as acceptor of electrons.

The glucose oxidase activity is expressed in Glucose Oxidase Units/g (GODU/g) (reaction conditions: pH 5.6, temperature 30°C, reaction time 30 min). One unit of GODU is defined as the amount of enzyme which oxidises 1 μmol of β‐[d]{.smallcaps}‐glucose in 1 min. In the assay, the reaction catalysed by the glucose oxidase is coupled with a second one catalysed by a peroxidase. This peroxidase uses the formed hydrogen peroxide to oxidise 2,2‐azino‐di‐(3‐ethylbenzthiazoline)‐6‐sulfonate (ABTS). The oxidation of the latter substrate is measured spectrophotometrically at 405 nm and is proportional to the amount of glucose oxidised during the first reaction.

Data showed that catalase activity was not sufficient to interfere with the determination of food enzyme activity.

The glucose oxidase has been characterised regarding its activity depending on temperature and pH. The glucose oxidase is active at temperatures up to 70°C (with an optimum of 50--60°C at pH 6) and within a pH range of 2--10 (with an optimum of pH 3--5.5 at 30°C). The thermostability of the food enzyme was tested over a range of 25--90°C after a pre‐incubation at the different temperatures for 30 min at pH 6. The activity itself was measured at pH 6 and 30°C. The food enzyme retained its activity at temperatures up to 60°C. At higher temperatures, the food enzyme rapidly loses its activity; above 80°C, no activity remains after 30 min.

### 3.1.4. Information on the source material {#efs25319-sec-0016}

#### 3.1.4.1. Information related to the genetically modified microorganism {#efs25319-sec-0017}

The glucose oxidase is produced with the genetically modified production strain *A. oryzae* NZYM‐KP, which is deposited in the ■■■■■ with the deposit number ■■■■■.

#### 3.1.4.2. Characteristics of the parental and recipient microorganisms {#efs25319-sec-0018}

The *A. oryzae* recipient strain, ■■■■■, has been developed from the parental strain *A. oryzae* ■■■■■. The taxonomic classification of both the parental and the recipient strain has been confirmed by ■■■■■. The recipient strain ■■■■■ has a long history of use in the production of food enzymes. The strain was developed from the parental strain, ■■■■■: ■■■■■■■■■■■■■■■■■■■■

■■■■■

#### 3.1.4.3. Characteristics of introduced sequences {#efs25319-sec-0019}

The gene encoding the glucose oxidase, ■■■■■

■■■■■

#### 3.1.4.4. Description of the genetic modification process {#efs25319-sec-0020}

■■■■■ A clone showing increased expression of glucose oxidase was selected as the production strain (NZYM‐KP).

#### 3.1.4.5. Safety aspects of the production strain {#efs25319-sec-0021}

■■■■■

The production strain NZYM‐KP differs from the recipient strain ■■■■■

■■■■■

■■■■■

The genetic modifications do not raise safety concerns.

### 3.1.5. Manufacturing process {#efs25319-sec-0022}

The food enzyme is manufactured according to Food Hygiene Regulation (EC) No 852/2004[5](#efs25319-note-1011){ref-type="fn"}, with food safety procedures based on Hazard Analysis and Critical Control Points (HACCP), and in accordance with Good Manufacturing Practice (GMP).

The food enzyme is produced by a pure culture in a contained, ■■■■■, ■■■■■ fermentation system with conventional process controls in place.

After completion of the fermentation, the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is then further purified and concentrated by ■■■■■.

After stabilisation with ■■■■■, the food enzyme preparation is commercialised as a liquid and solid product.

The production strain could not be detected in ■■■■■

No DNA from the production strain was detected in ■■■■■

The Panel considered the information provided on the raw materials and the manufacturing process as to be sufficient.

### 3.1.6. Safety for the environment {#efs25319-sec-0023}

The production strain and its DNA were not detected in the final product. Therefore, the Panel concluded that there is no safety concern for the environment.

### 3.1.7. Case of need and intended conditions of use {#efs25319-sec-0024}

The original uses proposed by the applicant were baking and cereal‐based processes. In the course of the evaluation process, the applicant informed EFSA about withdrawal of the intended use in cereal based processes.

The resulting intended use is in baking processes at recommended use level up to 1,000 GODU/kg flour, corresponding to 13.9 mg TOS/kg flour.

In baking processes, glucose oxidase is used to increase the strength of the dough and facilitate its handling. The food enzyme is added during mixing of the raw materials.

### 3.1.8. Reaction and fate in food {#efs25319-sec-0025}

The glucose oxidase catalyses the oxidation of β‐[d]{.smallcaps}‐glucose to [d]{.smallcaps}‐glucono‐δ‐lactone and hydrogen peroxide using molecular oxygen as acceptor of electrons.

The [d]{.smallcaps}‐glucono‐δ‐lactone is permitted as a carrier in food enzymes.[6](#efs25319-note-1012){ref-type="fn"}

Hydrogen peroxide is considered to be the active agent responsible for the intended function of glucose oxidase in dough preparation. Hydrogen peroxide reinforces the gluten network via oxidation of cysteine residues and the resulting formation of disulfide bonds (Bonet et al., [2006](#efs25319-bib-0002){ref-type="ref"}). In addition, hydrogen peroxide has been shown to induce the formation of dityrosine cross links through oxidative coupling of tyrosine residues in gluten proteins (Tilley et al., [2001](#efs25319-bib-0016){ref-type="ref"}; Takasaki et al., [2005](#efs25319-bib-0015){ref-type="ref"}). These reactions naturally occur during the preparation of dough; the use of the glucose oxidase is intended to promote these reactions, and thereby improve and/or standardise the rheological properties of the dough. Although the food enzyme contains catalase, which degrades hydrogen peroxide in the dough, the applicant demonstrated that the activity present was insufficient to affect the levels of hydrogen peroxide produced by the action of the glucose oxidase.

The glucose oxidase is specific in its action under the intended conditions of use and is not known to catalyse other reactions than this oxidation of glucose leading to the formation of hydrogen peroxide and [d]{.smallcaps}‐glucono‐1,5‐lactone. Concerning the reactions of hydrogen peroxide in the dough, there is no expectation of oxidation products other than those normally formed during the dough‐making and baking processes.

According to the data provided on the thermostability, it is anticipated that the glucose oxidase is inactivated during baking processes under the conditions of use.

3.2. Dietary exposure {#efs25319-sec-0026}
---------------------

Dietary exposure estimates were calculated using the methodology described in the CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, [2016](#efs25319-bib-0009){ref-type="ref"}). The assessment of the food processes covered in this opinion involved selection of relevant food groups and application of process and technical conversion factors (Appendix [B](#efs25319-sec-1003){ref-type="sec"}). These input data were subject to a stakeholder consultation through open calls,[7](#efs25319-note-1013){ref-type="fn"} and adjusted in accordance with feedback received.

### 3.2.1. EFSA Comprehensive European Food Consumption Database {#efs25319-sec-0027}

Since 2010, the EFSA Comprehensive European Food Consumption Database (hereinafter the EFSA Comprehensive Database[8](#efs25319-note-1014){ref-type="fn"}) has been populated with detailed national data on food consumption. Competent authorities in European countries provide EFSA with data regarding the level of food consumption by individual consumers, as taken from the most recent national dietary survey in their country (EFSA, [2011a](#efs25319-bib-0006){ref-type="ref"}).

The food consumption data gathered by EFSA were collected using different methodologies and thus direct country‐to‐country comparisons should be made with caution. Depending on the food category and the level of detail used in exposure calculations, uncertainties might be introduced owing to subjects possibly underreporting and/or misreporting of consumption amounts. Nevertheless, the EFSA Comprehensive Database is the best available source of food consumption data across Europe.

Food consumption data from the following population groups: infants, toddlers, children, adolescents, adults and the elderly were used for the exposure assessment. For the present assessment, food consumption data were available from 33 different dietary surveys carried out in 19 European countries (Appendix [A](#efs25319-sec-1002){ref-type="sec"}).

Consumption records were codified according to the FoodEx classification system (EFSA, [2011b](#efs25319-bib-0007){ref-type="ref"}).

### 3.2.2. Exposure assessment methodology {#efs25319-sec-0028}

Chronic exposure was calculated based on individual consumption, averaged over the total survey period, excluding surveys with only one day per subject. High‐level exposure/intake was calculated for only those population groups, in which the sample size was sufficiently large to allow calculation of the 95th percentile (EFSA, [2011a](#efs25319-bib-0006){ref-type="ref"}).

The exposure per FoodEx category was subsequently added to derive an individual total exposure per day. Finally, these exposure estimates were averaged over the number of survey days and normalised for individual body weight (bw), resulting in an individual average exposure/day per kg bw for the survey period. This was done for all individuals in the survey and per age class, resulting in distributions of individual average exposure per survey and age class. Based on these distributions, the mean and 95th percentile exposures were calculated per survey for the total population and per age class.

### 3.2.3. Exposure to food enzyme--TOS according to the intended use proposed by the applicant {#efs25319-sec-0029}

Dietary exposure to the food enzyme--TOS was based on intended use and the recommended maximum use levels of the food enzyme--TOS provided by the applicant (Table [2](#efs25319-tbl-0002){ref-type="table"}). Food enzyme--TOS exposure was calculated from foods produced involving a baking process.

Relevant food groups and/or individual foods were selected from the Comprehensive Database and were assumed to always contain the food enzyme--TOS at the maximum recommended use level. This will result in an overestimation of exposure to food enzyme--TOS.

To facilitate matching of the reported use levels for baking processes with foods identified in the Comprehensive Database, the selected foods were disaggregated to ingredient level as appropriate, and converted into the corresponding raw material, i.e. flour, via the application of conversion factors (Appendix [B](#efs25319-sec-1003){ref-type="sec"}). For example, consumption of 100 g of bread was converted into an intake of 70 g flour (recipe fraction of 0.7) and then multiplied by 1.17 mg TOS/kg flour, as provided by the applicant, to arrive at an exposure of 0.08 mg TOS/100 g bread.

Dietary exposure to the food enzyme--TOS was calculated by multiplying values reported for each food category by their respective consumption amount per kilogram of body weight separately for each individual in the database. Table [2](#efs25319-tbl-0002){ref-type="table"} provides an overview of the derived exposure estimates. The average and 95th percentile exposure to the food enzyme--TOS per age class, country and survey are reported in Appendix [C](#efs25319-sec-1004){ref-type="sec"} -- Table [1](#efs25319-tbl-0001){ref-type="table"}. The contribution of the food enzyme--TOS from each FoodEx category to the total dietary exposure is indicated in Appendix [C](#efs25319-sec-1004){ref-type="sec"} -- Table [2](#efs25319-tbl-0002){ref-type="table"}.

###### 

Summary of estimated dietary exposure to food enzyme--TOS in six population groups

  Population group                                 Estimated exposure (mg/kg bw per day)                                                                                   
  ------------------------------------------------ --------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  Age range                                        3--11 months                            12--35 months       3--9 years          10--17 years        18--64 years        ≥ 65 years
  Min.--max. mean (number of surveys)              0.010--0.042 (6)                        0.036--0.088 (10)   0.038--0.083 (18)   0.023--0.055 (17)   0.017--0.034 (17)   0.016--0.029 (14)
  Min.--max. 95th percentile (number of surveys)   0.057--0.119 (5)                        0.083--0.148 (7)    0.071--0.156 (18)   0.041--0.109 (17)   0.032--0.066 (17)   0.030--0.053 (14)

bw: body weight.

John Wiley & Sons, Ltd

### 3.2.4. Uncertainty analysis {#efs25319-sec-0030}

In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, [2006](#efs25319-bib-0004){ref-type="ref"}), the following sources of uncertainties have been considered and are summarised in Table [3](#efs25319-tbl-0003){ref-type="table"}.

###### 

Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate

  Sources of uncertainties                                                                                                                 Direction of impact
  ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------
  **Model input data**                                                                                                                     
  Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard                        +/−
  Use of data from food consumption survey of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)   \+
  Possible national differences in categorisation and classification of food                                                               +/−
  **Model assumptions and factors**                                                                                                        
  FoodEx categories included in the exposure assessment were assumed to always contain the food enzyme--TOS                                \+
  Exposure to food enzyme--TOS was always calculated based on the recommended maximum use level                                            \+
  Selection of broad FoodEx categories for the exposure assessment                                                                         \+
  Use of recipe fractions in disaggregation FoodEx categories likely to contain the food enzyme                                            +/−
  Use of technical factors in the exposure model                                                                                           +/−

+: uncertainty with potential to cause overestimation of exposure; −: uncertainty with potential to cause underestimation of exposure.

John Wiley & Sons, Ltd

The conservative approach applied to the exposure estimate to food enzyme--TOS, in particular, assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to a considerable overestimation of the exposure.

3.3. Toxicological data {#efs25319-sec-0031}
-----------------------

A battery of toxicological tests including a bacterial gene mutation assay (Ames test), an *in vitro* mammalian chromosomal aberration test and a repeated dose 90‐day oral toxicity study in rats has been provided. The batch 4 (Table [1](#efs25319-tbl-0001){ref-type="table"}) which is used for toxicological testing has lower specific activity compared to the batches used for commercialisation, and thus is considered cruder and suitable for toxicological testing.

The principal enzyme activity of the tested material is glucose oxidase, producing hydrogen peroxide (cytotoxic and mutagenic compound *in vitro*) in the presence of glucose. Therefore, in the genotoxicity tests, the glucose oxidase was inactivated by heat treatment for 30 min at 60°C at pH 2 and subsequently adjusted to neutral pH. Considering the fact that the food enzyme is intended to be used in baking processes, the Panel decided that this inactivation is representative for the food enzyme as consumed.

### 3.3.1. Genotoxicity {#efs25319-sec-0032}

#### 3.3.1.1. Bacterial reverse mutation test {#efs25319-sec-0033}

In order to investigate the potential of the food enzyme to induce gene mutations, a bacterial reverse mutation assay (Ames test) was performed according to OECD Test Guideline 471 (OECD, [1997a](#efs25319-bib-0012){ref-type="ref"}) and following Good Laboratory Practice (GLP) in four strains of *Salmonella* Typhimurium (TA1535, TA100, TA1537 and TA98) and *E. coli* WP2uvrA. The test was performed in the presence or absence of metabolic activation applying the 'treat and plate assay' for *Salmonella* Typhimurium and the direct plate incorporation assay for *E. coli*. Two experiments were carried out in triplicate plating using six concentrations of the food enzyme (156, 313, 625, 1,250, 2,500 and 5,000 μg dry matter/plate, corresponding to 127, 256, 511, 1,021, 2,042 and 4,084 μg TOS/plate), using appropriate positive controls and sterile water as a negative control. All positive control chemicals induced significant increases in revertant colony numbers, confirming the sensitivity of the tests and the efficacy of the S9‐mix. No toxicity was observed at any dose level of the test substance. However, growth stimulation was observed in most of the tested conditions after treatment with the food enzyme. This increase did not result in a noticeable increase in the corresponding levels of revertants. Upon treatment with the food enzyme, the numbers of the revertant colonies were comparable to the values observed in the vehicle control groups in any tester strain, both in the presence and absence of metabolic activation. The Panel concluded that the food enzyme did not induce gene mutations in the bacterial reverse mutation assay under the test conditions employed for this study.

#### 3.3.1.2. *In vitro* mammalian chromosome aberration test {#efs25319-sec-0034}

The *in vitro* chromosome aberration test was carried out according to the OECD Test Guideline 473 (OECD, [1997b](#efs25319-bib-0013){ref-type="ref"}) and following GLP. Whole blood cultures were treated with purified water (negative control), the food enzyme or appropriate positive controls both in the presence and absence of metabolic activation. Based on the results of a preliminary cytotoxicity assay performed in a range of concentrations from 38 to 5,000 μg food enzyme/mL, the cells were treated with 3,441, 4,301 and 5,376 μg food enzyme/mL (corresponding to 368, 460 and 575 μg TOS/mL) applying a short‐term treatment (3 h followed by 17 h recovery) in the presence and absence of S9‐mix. The highest concentration induced approximately 32% and 0% reduction in mitotic index in the absence and presence of S9, respectively. In the second experiment, the concentrations of the food enzyme tested were 501, 1,187 and 2,109 μg food enzyme/mL (corresponding to 54, 127 and 226 μg TOS/mL) in a continuous treatment (20+0 h) without S9, and 3,613, 4,250 and 5,000 μg food enzyme/mL (corresponding to 387, 455 and 535 μg TOS/mL) for the short treatment in the presence of S9‐mix. The highest concentrations induced approximately 49% and 0% reduction in mitotic index in the absence and presence of S9, respectively. Two hundred metaphases per experimental point were analysed. The Panel noted inconsistencies in the data reporting between the summary tables and the detailed presentation of type and number of chromosomal aberrations observed. Overall, no statistically significant increase in the frequency of chromosomal aberrations was observed in the treated cultures compared to the negative controls. One exception was the intermediate concentration tested (4,301 μg food enzyme/mL) in the short‐term treatment in the presence of S9‐mix, showing a frequency of aberrations above the historical vehicle control range; this increase was not dose‐related, not statistically significant and not reproducible, and thus, it was considered not biologically relevant. In addition, the Panel noted a value above the observed range of the vehicle controls also at the mid‐dose tested in the short‐term treatment without S9‐mix (4,301 μg food enzyme/mL). The increase was not dose‐related or statistically significant, therefore was not considered of biological relevance. The frequencies of cells with numerical aberrations fell within the historical negative control ranges in all tested conditions. The Panel concluded that the food enzyme did not induce chromosomal aberration in cultured human peripheral blood lymphocytes when tested under the experimental conditions employed for this study.

### 3.3.2. Repeated dose 90‐day oral toxicity study in rodents {#efs25319-sec-0035}

A repeated dose 90‐day oral toxicity study was performed according to OECD Test Guideline 408 (OECD, [1998](#efs25319-bib-0014){ref-type="ref"}) and following good laboratory practice (GLP). Four groups of 10 male and 10 female specific‐pathogen‐free Sprague--Dawley (Crl:CD(SD)IGS BR) rats were given the food enzyme by gavage at dose levels of 114, 341 or 1,135 mg TOS/kg bw per day. Controls received the vehicle (water).

There was one unscheduled death in the high‐dose male group during week 9 of the study, probably due to misdosing.

In high‐dose females, non‐significant decreases in food consumption, body weight and body weight gain were observed. These changes were only slight (below 10% compared to controls) and are not considered to be adverse.

In the FOB tests for neurotoxicity (performed from week 1 to week 13), occasional deviations from the control were observed. These sporadic changes did not show a dose‐response relationship and were only seen at single time‐points and therefore they were not considered to be adverse.

In haematology, a statistically significant increase in prothrombin time was observed in the high‐dose males. This was due to the high value in one animal and therefore not considered to be of toxicological concern. In the low‐ and mid‐dose males, statistically significant increases in neutrophils associated with a non‐significant increase in white blood cell counts were observed. No differences were observed in females. A statistically significant increase in mean absolute spleen weight was observed in the low‐ and mid‐dose males without any pathological changes. As this increase was slight, and no dose‐related, this effect was not considered relevant.

In clinical chemistry, the values for which significant differences were observed were sporadic, not dose‐related and were small in magnitude. The effects were considered to be of no toxicological relevance.

At necropsy and histopathology, evaluation of dark (3/10) and spongy lung lobes (2/10) and/or subacute interstitial pneumonia in high‐dose males (2/10) was observed. One of these animals also had oesophageal myositis. The 90‐day study authors ascribe these lung effects to the gavage‐dosing procedure, but it is noteworthy that both occurred only in the high dose and not at any other dose level or in the females. In addition, the intercurrent death (i.e. animal 37) had the same type of lung damage. In the absence of better evidence that these lung effects are indeed the result of gavage misdosing, these observations should be taken into account.

No other significant effects were observed.

Overall, the Panel derived a no‐observed‐adverse‐effect level (NOAEL) based on the mid‐dose level of 341 mg TOS/kg bw per day.

The NOAEL derived from 341 mg TOS/kg bw per day was compared to the exposure estimates of 0.010--0.088 mg/kg bw per day at the mean and from 0.030 to 0.156 mg TOS/kg bw per day at the 95th percentile, resulted in a margin of exposure (MOE) above 2,186, indicating that there is no safety concern.

3.4. Allergenicity {#efs25319-sec-0036}
------------------

The allergenicity assessment considers only the food enzyme and not any carrier or other excipient which may be used in the final formulation.

The potential allergenicity of glucose oxidase produced with the genetically modified *A. oryzae* strain NZYM‐KP was assessed by comparison of its amino acid sequence with those of known allergens according to the 'EFSA Scientific opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed of the Scientific Panel on Genetically Modified Organisms' (EFSA GMO Panel, [2010](#efs25319-bib-0010){ref-type="ref"}). Using higher than 35% identity in a window of 80 amino acids as the criterion, one match was found. The matching allergen was Mala s 12 from *Malassezia sympodialis* (formerly known as *Pityrosporum*), which is a ubiquitous component of the human skin microbiome. Mala s 12 has sequence similarity with the glucose‐methanol‐choline oxidoreductase enzyme superfamily (Zargari et al., [2007](#efs25319-bib-0017){ref-type="ref"}), which also includes glucose oxidase. Mala s 12 is a known contact allergen that can induce IgE‐ and T‐cell‐mediated allergic reaction in atopic eczema patients characterised by an impaired skin barrier. Considering that oral allergic reactions are mediated by IgE, elicitation reactions upon dietary exposure to this food enzyme cannot be excluded but as the yeast that expresses this allergen is an ubiquitous component of the skin microflora, the likelihood of such elicitation reactions to occur after oral exposure through food is considered to be low.

No oral or respiratory allergic reactions to this glucose oxidase have been reported.

The applicant provided a study by Bindlev‐Jensen et al. ([2006](#efs25319-bib-0001){ref-type="ref"}) who investigated the possible cross reactivity of 19 different commercial food enzymes in allergic patients (400 patients allergic to inhalation allergens, food allergens, allergens of bee or wasp). Glucose oxidase from a genetically modified *A. oryzae* donor organism was positive in the skin prick test in three patients. The enzyme was further tested by ingestion (double‐blind, placebo‐controlled food challenge (DBPCFC)) and found to be negative to both active and placebo challenges. Despite the fact that no allergic reactions have been observed in these individuals, no conclusion can be drawn since the amino acid sequences of the allergens to which the patients were sensitised are not known.

The Panel considers that under the intended condition of use the risk of allergic sensitisation and elicitation reactions upon dietary exposure to this food enzyme cannot be excluded but the likelihood of such reactions occurring is considered to be low.

Conclusions {#efs25319-sec-0037}
===========

Based on the microbial source, the genetic modifications, the manufacturing process, the compositional, biochemical, toxicological data and the dietary exposure assessment, the Panel concluded that the food enzyme glucose oxidase produced with the genetically modified *A. oryzae* strain NZYM‐KP does not give raise to safety concerns under the intended conditions of use.

Regarding the allergenicity assessment, the risk of allergic sensitisation and elicitation reactions upon dietary exposure to this food enzyme cannot be excluded, but the likelihood of such reactions to occur can be considered to be low.

Documentation provided to EFSA {#efs25319-sec-0038}
==============================

Dossier 'Glucose oxidase from a genetically modified strain of *Aspergillus oryzae* (strain NZYM‐KP)'. August 2013. Submitted by Novozymes A/S.Additional information submitted on 3 September 2014 by the applicant.Additional information submitted in October 2017 by the applicant.

Abbreviations {#efs25319-sec-0039}
=============

ABTS2,2‐azino‐di‐(3‐ethylbenzthiazoline)‐6‐sulfonatebwbody weightCASChemical Abstracts ServiceCFUcolony forming unitsDBPCFCdouble‐blind, placebo‐controlled food challenge■■■■■■■■■■EINECSEuropean Inventory of Existing Commercial Chemical SubstancesGLPgood laboratory practiceGMMgenetically modified microorganismGMPGood Manufacturing PracticeGODUGlucose Oxidase UnitsHACCPHazard Analysis and Critical Control PointsIgEimmunoglobulin E■■■■■■■■■■IUBMBInternational Union of Biochemistry and Molecular BiologyMOEmargin of exposureNOAELno‐observed‐adverse‐effect levelOECDOrganisation for Economic Cooperation and DevelopmentPCRpolymerase chain reactionQPSqualified presumption of safetySDS‐PAGEsodium dodecyl sulfate‐poly acrylamide gel electrophoresisTOStotal organic solids

Appendix A -- Population groups considered for the exposure assessment {#efs25319-sec-1002}
======================================================================

 {#efs25319-sec-0040}

PopulationAge rangeCountries with food consumption surveys covering more than one dayInfantsFrom 12 weeks up to and including 11 months of ageBulgaria, Denmark, Finland, Germany, Italy, United KingdomToddlersFrom 12 months up to and including 35 months of ageBelgium, Bulgaria, Denmark, Finland, Germany, Italy, Netherlands, Spain, United KingdomChildren[a](#efs25319-note-1015){ref-type="fn"}From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Latvia, Netherlands, Spain, Sweden, United KingdomAdolescentsFrom 10 years up to and including 17 years of ageAustria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Italy, Latvia, Spain, Sweden, United KingdomAdultsFrom 18 years up to and including 64 years of ageAustria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania, Spain, Sweden, United KingdomThe elderly[a](#efs25319-note-1015){ref-type="fn"}From 65 years of age and olderAustria, Belgium, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Romania, Sweden, United Kingdom[^1]

Appendix B -- FoodEx categories used to derive exposure estimates for the food enzyme--TOS and the respective conversion factors {#efs25319-sec-1003}
================================================================================================================================

 {#efs25319-sec-0041}

FoodEx codeFoodEx categoryConversion factor from FoodEx food group to raw material[a](#efs25319-note-1017){ref-type="fn"}Recipe fraction[b](#efs25319-note-1018){ref-type="fn"}mg TOS/kg flourA.01Grains and grain‐based products (unspecified)0.8113.9A.01.03Grain milling products (unspecified)1113.9A.01.03.001Wheat milling products (unspecified)1113.9A.01.03.001.001Wheat flour, brown1113.9A.01.03.001.002Wheat flour, Durum1113.9A.01.03.001.003Wheat flour, white1113.9A.01.03.001.004Wheat flour, wholemeal1113.9A.01.03.001.005Graham flour1113.9A.01.03.001.006Wheat flour, gluten free1113.9A.01.03.001.014Wheat starch1.2113.9A.01.03.002Rye milling products (unspecified)1113.9A.01.03.002.001Rye flour, gluten free1113.9A.01.03.002.002Rye flour, light1113.9A.01.03.002.003Rye flour, medium1113.9A.01.03.002.004Rye flour, wholemeal1113.9A.01.03.003Buckwheat milling products (unspecified)1113.9A.01.03.003.001Buckwheat flour1113.9A.01.03.004Corn milling products (unspecified)1113.9A.01.03.004.001Corn flour1113.9A.01.03.004.003Corn starch1.3113.9A.01.03.005Oat milling products (unspecified)1113.9A.01.03.005.002Oat flour1113.9A.01.03.005.004Oat starch1.2113.9A.01.03.006Rice milling products (unspecified)1113.9A.01.03.006.001Rice flour1113.9A.01.03.006.002Rice flour, white1113.9A.01.03.006.003Rice flour, instant1113.9A.01.03.006.004Rice starch1.2113.9A.01.03.007Spelt milling products1113.9A.01.03.008Other milling products (unspecified)1113.9A.01.03.008.001Amaranth flour1113.9A.01.03.008.002Barley flour1113.9A.01.03.008.003Chapatti flour1113.9A.01.03.008.004Flour mix, wheat/rye/barley/oats1113.9A.01.03.008.005Millet flour1113.9A.01.03.008.007Sorghum flour1113.9A.01.04Bread and rolls (unspecified)10.713.9A.01.04.001Wheat bread and rolls10.713.9A.01.04.002Rye bread and rolls10.713.9A.01.04.003Mixed wheat and rye bread and rolls10.713.9A.01.04.004Multigrain bread and rolls10.713.9A.01.04.005Unleavened bread, crisp bread and rusk (unspecified)10.813.9A.01.04.005.001Crisp bread, rye wholemeal10.913.9A.01.04.005.002Crisp bread, rye, light10.913.9A.01.04.005.003Crisp bread, wheat, wholemeal10.913.9A.01.04.005.004Crisp bread, wheat, light10.913.9A.01.04.005.005Rusk, light10.913.9A.01.04.005.006Rusk, wholemeal10.913.9A.01.04.005.007Pita bread10.713.9A.01.04.005.008Matzo10.913.9A.01.04.005.009Tortilla10.713.9A.01.04.006Other bread10.713.9A.01.04.007Bread products10.713.9A.01.07Fine bakery wares (unspecified)10.513.9A.01.07.001Pastries and cakes (unspecified)10.513.9A.01.07.001.001Beignets10.1513.9A.01.07.001.002Buns10.713.9A.01.07.001.003Cake from batter10.2513.9A.01.07.001.004Cheese cream cake10.2413.9A.01.07.001.005Cheese cream sponge cake10.2413.9A.01.07.001.006Chocolate cake10.2413.9A.01.07.001.007Chocolate cake with fruits10.2413.9A.01.07.001.008Cream cake10.2413.9A.01.07.001.009Cream cheese cake10.2413.9A.01.07.001.010Cream custard cake10.2413.9A.01.07.001.011Cream custard sponge cake10.2413.9A.01.07.001.012Croissant10.513.9A.01.07.001.013Croissant, filled with chocolate10.513.9A.01.07.001.014Croissant, filled with cream10.513.9A.01.07.001.015Croissant, filled with jam10.513.9A.01.07.001.016Croquembouche10.1513.9A.01.07.001.017Doughnuts10.2413.9A.01.07.001.018Éclair10.1513.9A.01.07.001.019Flan10.513.9A.01.07.001.020Fruit cake10.613.9A.01.07.001.021Fruit pie10.1513.9A.01.07.001.022Cheese pie10.1513.9A.01.07.001.023Fruit tart10.1513.9A.01.07.001.024Gingerbread10.613.9A.01.07.001.025Gougere10.1513.9A.01.07.001.026Kringles10.2513.9A.01.07.001.027Nut cream cake10.2413.9A.01.07.001.028Pancakes10.2513.9A.01.07.001.029Profiterole10.1513.9A.01.07.001.030Pyramid cake10.2513.9A.01.07.001.031Rhubarb flan10.1513.9A.01.07.001.032Scone10.513.9A.01.07.001.033Sponge dough10.2513.9A.01.07.001.034Sponge cake10.2513.9A.01.07.001.035Sponge cake roll10.2513.9A.01.07.001.036Muffins10.2513.9A.01.07.001.037Waffles10.2513.9A.01.07.001.038Apple strudel10.1513.9A.01.07.001.039Cream‐cheese strudel10.2413.9A.01.07.001.040Cheese pastry goods from puff pastry10.1513.9A.01.07.001.041Croissant from puff pastry10.613.9A.01.07.001.042Brioche10.513.9A.01.07.001.044Lebkuchen10.613.9A.01.07.001.045Dumpling10.513.9A.01.07.001.046Cake marbled, with chocolate10.513.9A.01.07.001.047Marzipan pie10.2513.9A.01.07.001.048Baklava10.1513.9A.01.07.002Biscuits (cookies)10.913.9A.01.07.002.001Biscuits, sweet, plain10.913.9A.01.07.002.002Biscuits, chocolate filling10.8113.9A.01.07.002.003Biscuits, cream filling10.8113.9A.01.07.002.004Biscuits, fruit filling10.8113.9A.01.07.002.005Biscuits, vanilla filling10.8113.9A.01.07.002.006Butter biscuits10.8113.9A.01.07.002.007Biscuit, iced10.8113.9A.01.07.002.008Speculaas10.913.9A.01.07.002.009Biscuits, sweet, wheat wholemeal10.913.9A.01.07.002.010Biscuits, oat meal10.913.9A.01.07.002.011Biscuits, spelt meal10.913.9A.01.07.002.012Biscuits, salty10.913.9A.01.07.002.013Biscuits, salty, with cheese10.8113.9A.01.07.002.014Sticks, salty10.8113.9A.17.03.003Biscuits, rusks and cookies for children10.913.9A.18.04.001Find bakery products for diabetics10.513.9A.19.01.001Sandwich and sandwich‐like meal10.3213.9A.19.01.002Pizza and pizza‐like pies10.313.9[^2][^3][^4]

Appendix C -- Dietary exposure estimates to the food enzyme--TOS in details {#efs25319-sec-1004}
===========================================================================

 {#efs25319-sec-0042}

Information for this appendix is provided in an Excel file (downloadable [https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5319\#efs25319-sup-0001](#efs25319-sup-0001){ref-type="supplementary-material"}).

The file contains two sheets, corresponding to two tables.

Table [1](#efs25319-tbl-0001){ref-type="table"}: Average and 95th percentile exposure to the food enzyme--TOS per age class, country and survey.

Table [2](#efs25319-tbl-0002){ref-type="table"}: The contribution of the food enzyme--TOS from each FoodEx category to the total dietary exposure.

Supporting information
======================

###### 

Dietary exposure estimates to the food enzyme--TOS in details

###### 

Click here for additional data file.

Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7--15.

Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, p. 1--6.

Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 64, 11.3.2011, p. 15--24.

Limit of detection: Pb: 0.5 mg/kg; As: 0.1 mg/kg; Cd: 0.05 mg/k; Hg: 0.03 mg/kg.

Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives. OJ L 226, 25.6.2004, p. 3--21.

Annex III Part 3 of the Reg. (EU) No 1130/2011 amending Annex III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives by establishing a Union list of food additives approved for use in food additives, food enzymes, food flavourings and nutrients.

<http://www.efsa.europa.eu/en/data/call/161110>

<http://www.efsa.europa.eu/en/food-consumption/comprehensive-database>

[^1]: The terms 'children' and 'the elderly' correspond, respectively, to 'other children' and the merge of 'elderly' and 'very elderly' in the Guidance of EFSA on the 'Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment' (EFSA, [2011a](#efs25319-bib-0006){ref-type="ref"}).

[^2]: TOS: total organic solids.

[^3]: Available online: <http://www.fao.org/fileadmin/templates/ess/documents/methodology/tcf.pdf>

[^4]: Derived from publically available recipe information, and/or food label information (such as Mintel\'s Global New Products Database <http://www.mintel.com/global-new-products-database>).
